CD44 and cancer: To evaluate the percentage of cells that would potentially have cancer stem cell features, we analyzed the surface expression of CD44 and CD24 in both our K14-derived cell lines but did not find any differences between K14+, K14−, K14.GFP+, and K14.GFP− cells (S7C and S7D Fig).